Target
Human TRAF3IP2 / ACT1
Synonyms
TRAF3IP2 | C6orf2 | C6orf4 | C6orf5 | CIKS | DKFZP586G0522 | Connection to IKK and SAPK/JNK | ACT1 | Adapter protein CIKS | NFkB-activating protein ACT1 | PSORS13 | TRAF3-interacting protein 2 | C6orf6 | TRAF3 interacting protein 2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Immunogen
Peptide with sequence C-PDTGHDSDKSDQ, from the internal region of the protein sequence according to NP_679211.1NP_001157753.1.
Specificity
Human TRAF3IP2 / ACT1. This antibody is expected to recognise both reported isoforms (NP_671733.1 and NP_679211.1).
Applications
- Western blot (1 - 3 µg/ml)
- Peptide Enzyme-Linked Immunosorbent Assay (1:2000)
Usage
Peptide ELISA: antibody detection limit dilution 1:2000. Western blot: Approx 65kD band observed in lysates of cell line MCF7 (calculated MW of 64.7kD according to NP_671733.1). Recommended concentration: 1-3 ug/ml.
Presentation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee